正常人扩展高频测听结果报告

目的 :研究正常人扩展高频听敏度 ,观察扩展高频听力随年龄增加的细微变化。方法 :用意大利Amplaid - 4 6 0型听力计 ,频率范围 8～ 18kHz。测试正常人 12 8人、2 5 6耳 ,17～ 5 0岁 ,男 92人 ,女 36人 ,其中17～ 2 9岁 90人 ,30～ 5 0岁 38人 ,12 5Hz～ 8kHz纯音各频率听阈≤ 2 0dBHL ,声导抗测听正常。以 5岁为一年龄段分 5组进行分析。结果 :1 正常年轻人 (17～ 2 9岁 )高频听阈总的趋势是随频率提高 ,听阈逐渐增加 ,出现率逐渐下降 ,在 14kHz以上频率更为显著 ;2 正常人 17～ 19岁、2 0～ 2 4岁、2 5～ 2 9岁、30～ 34岁、35岁以上各年龄组间 12、14、16、18kHz听阈相比差异有显著性 (P <0 0 5 ) ,随年龄增加听阈逐渐提高 ,高频听阈出现率逐渐下降 ,随频率增加各年龄组差距逐渐明显 ,14kHz以上频率最为明显。结论 :人耳的老化是一个逐渐的过程 ,随年龄增加听阈提高。频率越高受影响越明显。扩展高频纯音测听结果可反映耳蜗亚临床病理状态 ,有利于早期发现听觉感受器病变 ,可用于临床监测耳毒性听力损失和早期诊断梅尼埃病等     

Effect of clinical factors on trajectory of functional performance in patients undergoing hemodialysis

PurposeThis study aimed to investigate the association between clinical factors and temporary changes in functional performance in patients undergoing hemodialysis.MethodsThis was a retrospective, longitudinal observational study conducted from 2015 to 2017. Eight-two patients undergoing hemodialysis in the outpatient clinic were enrolled. Functional performance was measured using the Karnofsky Performance Status (KPS) scale. Collected data for analysis included demographics, laboratory parameters, and KPS scale scores. All participants were grouped into a high KPS cluster and a low KPS cluster based on dynamic changes in KPS scales from 2015 to 2017.ResultsParticipants in the high KPS cluster demonstrated an approximate trend, and those in the low KPS cluster demonstrated a low pattern. By stepwise selection model analysis, age (OR 1.12, 95% CI 1.03–1.23, p = 0.011), serum BUN (OR 1.08, 95% CI 1.02–1.16, p = 0.015), calcium levels (OR 3.24, 95% CI 1.2–8.73, p = 0.02), and beta-2-microglobulin (OR > 1.0, CI >1.00-<1.01, p = 0.031) showed risk for the low KPS cluster. Male sex (OR 0.20, 95% CI 0.04–0.96, p = 0.045) and albumin level (OR 0.02, 95% CI 0–0.4, p = 0.009) showed a low risk for the low KPS cluster.ConclusionsA different trajectory pattern was observed between the high and low KPS clusters in a 3-year period. Risk factors for the low KPS cluster were age, serum BUN, calcium, and beta-2-microglobulin levels. Male sex and serum albumin levels reduced the risk for the low KPS cluster.     

卵巢储备功能下降的不孕症女性抗苗勒管激素与体重指数的相关性研究

目的探究卵巢储备功能下降(DOR)不孕症患者抗苗勒管激素(AMH)水平与体重指数(BMI)的相关性。方法回顾性分析2016年6月至2019年6月于郑州大学第一附属医院生殖医学中心就诊的4010例DOR不孕症患者临床资料,根据年龄分为低龄组(≤35岁,n=1857)和高龄组(>35岁,n=2153),各组再根据BMI分为正常体重组(18.5 kg/m²≤BMI<24 kg/m²)和超重及肥胖组(BMI≥24 kg/m²),比较各组患者的血清AMH水平及其他潜在影响AMH的因素。结果多重线性回归分析显示:低龄组AMH水平与BMI呈负相关(β=-0.100,P<0.05);高龄组AMH水平与BMI无显著相关性(P>0.05)。此外,高龄组AMH水平与基础卵泡刺激素(bFSH)水平呈负相关(P<0.05),低龄组AMH与bFSH水平无显著相关性(P>0.05)。不同年龄组AMH水平均与窦卵泡数(AFC)呈正相关(P<0.05),与年龄无显著相关性(P>0.05)。结论≤35岁DOR不孕症女性BMI是血清AMH水平变化的独立影响因子,而>35岁DOR不孕症女性BMI与血清AMH水平变化无关。DOR不孕症患者的年龄不能独立预测血清AMH水平。     

Health dynamics shape life-cycle incomes

This paper empirically investigates the long-run effects of major health improvements on income growth in the United States. To isolate exogenous changes in health, the econometric model uses quasi-experimental variation in cardiovascular disease mortality across states over time. Based on data for the white population, the results show that there is a causal link between health and income per person, and they provide novel evidence that health dynamics shape life-cycle incomes. Life-cycle income profiles slope more strongly at the beginning and at the end of work life in 2000 than in 1960, indicating that age becomes a more prominent determinant of income dynamics over this period. The channels for this transformation include better health, higher educational attainment, and changing labor supply.     

社会活动对老年人认知功能的影响

目的 探讨社会活动对不同性别和年龄的中国老年人认知功能的影响。方法 运用2018年“中国老年健康影响因素跟踪调查”的15424份数据。通过MMSE-R量表评价老人认知功能。控制居住地、受教育水平、配偶、自评健康状态、慢性病等因素,运用二元logistic回归分析社会活动对不同性别、年龄段老人认知功能的作用。结果 我国60岁以上老年人认知障碍发生率为34.88%,串门/与朋友交往、家务、看电视听广播和棋牌是所有性别和年龄段的老人认知功能的保护因素。阅读书报是＞85岁组男性老年人认知功能的保护因素,健身运动、旅游是60~85岁组男性认知功能的保护因素;社会组织活动是＞85岁组女性老人认知功能的保护因素。结论 根据老人的状态和需求提供适宜的社会活动方案,重视老年人社会活动的指导和推广。     

Interleukin-6 and selected plasma proteins in healthy persons of different ages

In the present study, interleukin-6(IL-6) and several acute phase proteins were measured in healthy participants (23–87 years of age). A linear correlation between IL-6 and age was established with an increase of 0.016 pg/ml(00.004) per year of life. Whereas CRP remained below 0.5 mg/dl in all participants, an increase with age for fibrinogen and an inverse relation for albumin as well as transferrin were obtained. However, the increase of IL-6 did not correlate with any of these changes. IL-6 associated diseases may therefore occur more often with advancing age, but in healthy participants IL-6 does not explain the changing plasma protein pattern resembling that of an acute phase reaction.     

Action potentials of the rat diaphragm and their sensitivity to tetrodotoxin during postnatal development and old age

Summary Using the microelectrode technique, parameters of action potentials obtained from the diaphragm muscle fibres were studied at 3, 7, 14, 30 and 90 days of age and on 28–30 month old rats. The maximum rate of rise was always greater at the end-plate zone than at the extrajunctional parts of muscle fibre at all ages examined. A maximum difference of 40% was found in animals aged 7–30 days. Sensitivity to tetrodotoxin (TTX) was maximal 3 days after birth at the extrajunctiona zone (5×10^–8 M) and minimal at the end-plate zone (5×10^–6 M). This difference declined during the postnatal life until it had disappeared in old rats. The greater resistance of the end-plate zone action potentials to TTX and their greater maximum rate of rise is not apparently connected with the presence of acetylcholine sensitivity.     

Human acetylator genotype: Relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol

Polymorphic expression of arylamine N-acetyltransferase (EC 2.3.1.5) may be a differential risk factor in metabolic activation of arylamine carcinogens and susceptibility to cancers related to arylamine exposures. Human epidemiological studies suggest that rapid acetylator phenotype may be associated with higher incidences of colorectal cancer. We used restriction fragment length polymorphism analysis to determine acetylator genotypes of 44 subjects with colorectal cancer and 28 non-cancer subjects of similar ethnic background (i.e., approximately 25% Black and 75% White). The polymorphic N-acetyltransferase gene (NAT2) was amplified by the polymerase chain reaction from DNA templates derived from human colons of colorectal and non-cancer subjects. No significant differences inNAT2 allelic frequencies (i.e., WT, M1, M2, M3 alleles) or in acetylator genotypes were found between the colorectal cancer and non-cancer groups. No significant differences inNAT2 allelic frequencies were observed between Whites and Blacks or between males and females. Cytosolic preparations from the human colons were tested for expression of arylamine N-acetyltransferase activity. Although N-acetyltransferase activity was expressed for each of the arylamines tested (i.e., p-aminobenzoic acid, 4-aminobiphenyl, 2-aminofluorene, -naphthylamine), no correlation was observed between acetylator genotype and expression of human colon arylamine N-acetyltransferase activity. Similarly, no correlation was observed between subject age and expression of human colon arylamine N-acetyltransferase activity. These results suggest that arylamine N-acetyltransferase activity expressed in human colon is catalyzed predominantly by NAT1, an arylamine N-acetyltransferase that is not regulated byNAT2 acetylator genotype. The ability to determine acetylator genotype from DNA derived from human surgical samples should facilitate further epidemiological studies to assess the role of acetylator genotype in various cancers.     

Age as a prognostic factor in the malignant melanoma population

Background: The incidence of malignant melanoma is increasing faster than any other cancer, and the state of Florida has one of the highest incidence of melanoma in the United States. This increased incidence is thought to be due to the intense sunlight exposure and ultraviolet radiation exposure in the elderly population. With the increased emphasis on issues of aging, it is appropriate to study the role of age as a prognostic factor for malignant melanoma in the Florida population. Methods: A retrospective, computer-aided search identified 442 consecutively registered patients with malignant melanoma at the Cutaneous Oncology Program. All patients had stage 1 or 2 disease (cutaneous disease only) at diagnosis. Prognostic variables analyzed included the most powerful factors for stage 1 and 2 melanoma, tumor thickness, ulceration, and Clark level of invasion. Other prognostic variables included in the analysis were the clinical variables of sex and primary site (axial vs. extremity). The population was divided into patients 65 and >65 years of age. Results: Significant disease-free survival differences were encountered in the older population, with only 55% of the elderly population being disease free at 5 years compared with 65% for the younger population (p=0.0073). However, a greater percentage of patients with melanoma who were >65 years of age had ulcerated lesions (17.5% vs. 12.9%) and a greater percentage of thick lesions at diagnosis (67.2% vs. 62.7%). Both of these prognostic factors would bias the older population with a poorer survival. A stepwise regression analysis of the entire population was performed, treating age as a continuous variable. Surprisingly, increasing age along with tumor thickness were the only significant predictors for disease-free survival. After inclusion of these two prognostic variables, none of the other prognostic factors, including Clark level, ulceration, sex, and primary site, added to the prognostic model. Conclusions: From this analysis, it is apparent that geriatric patients with melanoma have a worse prognosis than a younger control population, even after the correction for the more commonly cited prognostic factors. This information should be used in mathematical modeling to identify high-risk populations who are candidates for perhaps more aggressive primary or adjuvant therapies.Presented at the 46th Annual Cancer Symposium of The Society of Surgical Oncology, Los Angeles, California, March 18–21, 1993.